Improved cardiovascular prevention using best CME practices: A randomized trial

Journal of Continuing Education in the Health Professions

Volumn 29, Issue 1, 2009, Pages 16-31

  Laprise, Réjean ^a   Thivierge, Robert ^a   Gosselin, Gilbert ^a,b   Bujas Bobanovic, Maja ^c   Vandal, Sylvie ^a   Paquette, Daniel ^a   Luneau, Micheline ^a   Julien, Pierre ^a   Goulet, Serge ^a   Desaulniers, Jean ^a   Maltais, Paule ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c SANOFI   (France)

Author keywords

Cardiovascular prevention; Continuing; Education; General practice; High risk cardiovascular patients; Knowledge translation; Medical; Physician performance; Practice guidelines

Indexed keywords

ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CLINICAL COMPETENCE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MEDICAL AUDIT; MEDICAL EDUCATION; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY;

CARDIOVASCULAR DISEASES; CLINICAL COMPETENCE; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUEBEC; RETROSPECTIVE STUDIES;

EID: 67249114707     PISSN: 08941912     EISSN: 1554558X     Source Type: Journal    
DOI: 10.1002/chp.20002     Document Type: Article

References (43)

1. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145-153.
2. Collins-Nakai R, Dagenais GR. 1998 Consensus conference on cardiovascular prevention. Can J Cardiol. 1999;15(suppl G):7G-16G.
3. Pyörälä K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J. 1994;15(10):1300-1331.
4. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. September 14-15, 1995. J Am Coll Cardiol. 1996;27(5):957-1047.
5. The Clinical Quality Improvement Network (CQIN) Investigators. Low incidence of assessment and modification of risk factors in acute care patients with high risk for cardiovascular events, particularly among females and the elderly. Am J Cardiol. 1995;76(8): 570-573.
6. Jackevicius C, Anderson G, Leiter L, Tu J. Use of statins in patients after acute myocardial infarction: does evidence change practice? Arch Intern Med. 2001;161(2):183-188.
7. EUROASPIRE Study Group. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J. 1997;18(10):1569-1582.
8. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001;22(7):554-572.
9. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet. 2001;357(9261):995-1001.
10. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273(19): 1509-1514.
11. McLaughlin TJ, Soumerai SB, Wison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996;156(7):799-805.
12. Pearson T, Laurora I, Chu H, Kafonek S. The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000;160(4):459-467.
13. Jencks SF, Cuerdon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries: a profile at state and national levels. JAMA. 2000;284(13):1670-1676.
14. Qureshi AI, Suri MF, Guterman LR, Hopkins LN. Ineffective secondary prevention in survivors of cardiovascular events in the US population. Report from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2001;161(13):1621-1628.
15. Amsterdam EA, Laslett L, Diercks D, Kirk JD. Reducing the knowledge-practice gap in the management of patients with cardiovascular disease. Prev Cardiol. 2002;5(1):12-15.
16. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J. 2003;145(3):438-444.
17. Gonzalez-Juanatey JR, Alegria-Ezquerra E, Asnar-Costa J, Bertomeu-Marinez V, Franch-Nadal J, Palma-Gamizf JL. Knowledge and implementation of cardiovascular risk clinical practice guidelines by general practitioners and specialists [in Spanish]. Rev Esp Cardiol. 2006;801-806.
18. Rich MW. From clinical trials to clinical practice: bridging the gap. JAMA. 2002;287(10):1321-1323.
19. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458-1465.
20. Marinopoulos SS, Dorman T, Ratanawongsa N, et al. Effectiveness of continuing medical education. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Evidence Report/Technology Assessment 149. AHRQ Publication No. 07-E006.
21. Davis D, Thompson O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA. 1999;282(9):867-874.
22. Bloom BS. Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews. Int J Technol Assess Health Care. 2005;21(3):380-385.
23. Davis DA, Thompson MA, Oxman AD, Haynes B. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995;274(9):700-705.
24. Green LW, Kreuter MW. Health Program Planning: An Educational and Ecological Approach. Boston, MA: McGraw-Hill; 2005.
25. Harris SB, Lank CN. Recommendations from the Canadian Diabetes Association: 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors. Can Fam Physician. 2004;50:425-433.
26. Genest J, Frohlich J, Fodor G, McPherson R; Working Group on Hypercholesterolemia and Other Dislipidemia. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ. 2003;169(9):921-924.
27. Campbell N; Canadian Hypertension Education Program. Canadian Hypertension Education Program: brief overview of 2004 recommendations. Can Fam Physician. 2004;50:1411-1412.
28. Stone JA, Arthur HM; Canadian Association of Cardiac Rehabilitation Guidelines Writing Group. Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention, second edition, 2004: executive summary. Can J Cardiol. 2005;21(suppl D):3D-19D.
29. Creager MA, Goldstone J, Hirshfeld JW Jr, et al; American College of Cardiology; American Heart Association; American College of Physicians Task Force on Clinical Competence; Society for Cardiovascular Angiography and Interventions; Society for Vascualr Medicine and Biology; Society for Vascular surgery. ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on peripheral vascular disease). Vasc Med. 2004;9(3):233-248.
30. Balas EA, Weingarten S, Garb CT, Blumenthal D, Austin Boren S, Brown GD. Improving preventive care by prompting physicians. Arch Intern Med. 2000;160(3):301-308.
31. Streja DA, Rabkin SW. Factors associated with implementation of preventive-care measures in patients with diabetes mellitus. Arch Intern Med. 1999;159(3):294-302.
32. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
33. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121-130.
34. Orelien JG. Model fitting in PROC GENMOD. Paper presented at: 26th Annual SAS Users Group International Conference, SUGI 26; April 22-25, 2001; Long Beach, CA. http://www2.sas.com/proceedings/sugi26/p264-26.pdf. Accessed July 20, 2007.
35. Bullard MJ, Emond SD, Graham TA, Ho K, Holroyd BR. Informatics and knowledge translation. Acad Emerg Med. 2007;14(11):996-1002.
36. Rabinowitz I, Tamir A. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care: cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record. Eur J Cardiovasc Prev Rehabil. 2005;12(1): 56-62.
37. Tamblyn R, Huang A, Perreault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ. 2003;169(6):549-556.
38. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patient's care. Lancet. 2003;362(9391): 1225-1230.
39. Davis D. Continuing education, guideline implementation, and the emerging transdisciplinary field of knowledge translation. J Contin Educ Health Prof. 2006;26(1):5-12.
40. Stone TT, Kivlahan CH, Cox KR. Evaluation of physician preferences for guideline implementation. Am J Med Qual. 1999;14(4): 170-177.
41. Tai-Seale M, McGuire TG, Zhang W. Time allocation in primary care office visits. Health Serv Res. 2007;42(5):1871-1894.
42. Hulscher ME, van Drenth BB, Mokkink HG, van der Wouden JC, Grol RP. Barriers to preventive care in general practice: the role of organizational and attitudinal factors. Br J Gen Pract. 1997;47(424): 711-714.
43. Goulet F, Jacques A, Gagnon R, et al. Performance assessment: family physicians in Montreal meet the mark) Can Fam Physician. 2002; 48:1337-1344.